![Houssam Zazgad](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Network origin in Houssam Zazgad first degree
Entity | Entity type | Industry | |
---|---|---|---|
PROMETHERA Biosciences SA
![]() PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
7
| Holding Company | Pharmaceuticals: Major | 7 |
Hepatic Cell Therapy Support SA
![]() Hepatic Cell Therapy Support SA BiotechnologyHealth Technology Part of Catalent, Inc., Hepatic Cell Therapy Support SA is a cell therapy manufacturing facility. The company is based in Charleroi, Belgium. Founded in 2011, the Belgian company operates as a cell therapy manufacturing facility. Hepatic Cell Therapy Support was acquired by Catalent, Inc. from PROMETHERA Biosciences SA on May 06, 2021 for $18.25 million.
1
| Subsidiary | Biotechnology | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Houssam Zazgad via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
GOLDEN EAGLE RETAIL GROUP LIMITED | Department Stores | Corporate Secretary | |
TIGENIX NV | Medical Specialties | Director/Board Member | |
ACESO LIFE SCIENCE GROUP LIMITED | Containers/Packaging | Director of Finance/CFO | |
MDXHEALTH SA | Medical Specialties | Director/Board Member | |
The Chartered Governance Institute
![]() The Chartered Governance Institute Miscellaneous Commercial ServicesCommercial Services The Chartered Governance Institute provides governance and compliance services. The company was incorporated by Royal Charter in 1891 and is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
FAR EAST HOLDINGS INTERNATIONAL LIMITED | Real Estate Investment Trusts | Director/Board Member | |
Institute of Chartered Accountants in England & Wales
![]() Institute of Chartered Accountants in England & Wales Miscellaneous Commercial ServicesCommercial Services The Institute of Chartered Accountants in England & Wales ensures that its members, students, and affiliates maintain the highest standards of professional competency and conduct to protect the public interest. The non-profit company is based in London, UK, and has subsidiaries in the United Kingdom. With over 150,000 members, the institute provides technical information, helplines, and communities to its members. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Oxford Brookes University | College/University | Undergraduate Degree | |
Tibotec Virco NV
![]() Tibotec Virco NV Miscellaneous Commercial ServicesCommercial Services Tibotec-Virco NV develops drugs and individualized disease management products. The firm also offers early stage research programs concentrating on the development of treatments for cancer, hepatitis C, and other infectious diseases. The company also provides HIV drug resistance testing and other analytical services in the United States, Japan, Europe, Canada, and Australia. It has operations in Belgium, North Carolina, Ireland, and the United Kingdom. It was founded in by Paul Stoffels in March, 2001 and is headquartered in Mechelen, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
University of Hong Kong | College/University | Masters Business Admin | |
CropDesign NV
![]() CropDesign NV Miscellaneous Commercial ServicesCommercial Services CropDesign NV develops traits for cereal crops. It delivers agronomic traits for the global commercial seed markets. The firm focuses on enhancing grain yield in crops such as corn and rice, and increasing biomass of energy crops. Its platform, TraitMill, lows evaluating the effect of genes on the performance of plants under different growing conditions, including drought and low nutrient stress. The company was founded in 1998 and is headquartered in Zwijnaarde, Blgium. | Miscellaneous Commercial Services | Director/Board Member | |
Université Libre de Bruxelles | College/University | Graduate Degree | |
Ogeda SA
![]() Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | Pharmaceuticals: Major | Director/Board Member | |
Hong Kong Institute of Certified Public Accountants
![]() Hong Kong Institute of Certified Public Accountants Miscellaneous Commercial ServicesCommercial Services Hong Kong Institute of Certified Public Accountants operates under the professional accountant’s ordinance and works in the public interest. It offers CPA qualification programme and promulgating financial reporting, auditing and ethical standards in Hong Kong. The company was founded on January 1, 1973 and is headquartered in Hong Kong. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
The Hong Kong Institute of Chartered Secretaries
![]() The Hong Kong Institute of Chartered Secretaries Miscellaneous Commercial ServicesCommercial Services The Hong Kong Institute of Chartered Secretaries is an independent professional body that promotes the role of its members in formulating and implementing good governance policies. The private company is based in Hong Kong, Hong Kong. It also aims to develop the profession of chartered secretary and chartered governance professional in mainland China. The institute was established in 1949 as an association of members of the Chartered Governance Institute and gained local status in 1994. It has more than 6,000 members and 3,200 students. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Biotechnological Enzymatic Catalyse NV
![]() Biotechnological Enzymatic Catalyse NV Food: Major DiversifiedConsumer Non-Durables Biotechnological Enzymatic Catalyse NV develops, produces and commercializes enzymatic systems for food preservation. It engages in the research, development and manufacturing of antimicrobial products for food safety. The firm's solutions are designed for use in the following: dairy products, fruit and vegetable juices, sauces and dressings and liquid egg products. The company was founded in 1992 and is headquartered in Ghent, Belgium. | Food: Major Diversified | Director/Board Member | |
Université Catholique de Louvain | College/University | Graduate Degree Corporate Officer/Principal | |
Vesalius Biocapital Partners SARL
![]() Vesalius Biocapital Partners SARL Investment ManagersFinance Vesalius Biocapital Partners SARL (Vesalius Biocapital Partners) is an independent venture capital firm founded in 2007 by Stéphane Verdood. The firm is headquartered in Luxembourg. | Investment Managers | Private Equity Investor | |
VOLUNTIS S.A. | Packaged Software | Director/Board Member | |
Apitope Technology (Bristol) Ltd.
![]() Apitope Technology (Bristol) Ltd. Miscellaneous Commercial ServicesCommercial Services Apitope Technology (Bristol) Ltd. is a European biotech company developing therapeutic vaccines for treating autoimmune and allergic diseases, including multiple sclerosis, Type 1 diabetes, Graves' disease, allergies and organ transplant rejection. The team at Apitope is developing potential therapies intended to selectively treat the underlying cause of a range of autoimmune diseases rather than simply treat the disease symptoms or non-specifically suppress the whole immune system. Apitope's approach is based on well-established scientific evidence published in leading scientific journals showing that soluble, synthetic peptides can selectively suppress abnormal immune responses and reinstate the normal immune balance and thereby, tolerance. The firm's strategy is to position itself as a significant player in the therapeutic peptide space and make it a partner of choice for pharmaceutical companies keen to develop disease modifiers for autoimmune conditions. It has a highly experienced senior management team, with a proven track record in discovering and developing innovative compounds. The company's lead product candidate is under investigation for the potential treatment of multiple sclerosis and is currently in Phase I clinical development. It is partnered with Merck-Serono (a division of Merck KGaA, Darmstadt, Germany), one of the leading companies in the development and marketing of MS therapies. | Miscellaneous Commercial Services | Director/Board Member | |
ProFibrix BV
![]() ProFibrix BV BiotechnologyHealth Technology ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands. | Biotechnology | Director/Board Member | |
Maize Technologies International GmbH | Director/Board Member | ||
The Belgian Venture Capital & Private Equity Association
![]() The Belgian Venture Capital & Private Equity Association Miscellaneous Commercial ServicesCommercial Services The Belgian Venture Capital & Private Equity Association provides equity capital to enterprises not quoted on a stock market. The firm develops new products and technologies to expand working capital, to make acquisitions or to strengthen a company’s balance sheet. The company was founded in 1986 and is headquartered in Brussels, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
AQ Invest BV | Corporate Officer/Principal | ||
Cliniques Universitaires Saint-Luc
![]() Cliniques Universitaires Saint-Luc Hospital/Nursing ManagementHealth Services Cliniques Universitaires Saint-Luc operates as a hospital which provides reference care and treats serious, rare or complex diseases of patients. The company was founded on August 23, 1976 and is headquartered in Brussels, Belgium. | Hospital/Nursing Management | Corporate Officer/Principal | |
Association of Chartered Certified Accountants (Hong Kong) | Corporate Officer/Principal | ||
Vesalius Biocapital II Partners SARL | Founder | ||
Solvay Business School of Economics & Management | College/University | Undergraduate Degree | |
HAO TIAN INTERNATIONAL CONSTRUCTION INVESTMENT GROUP LIMITED | Finance/Rental/Leasing | Chief Executive Officer | |
Bio-Sourcing SA
![]() Bio-Sourcing SA BiotechnologyHealth Technology Bio-Sourcing SA develops and markets biological drugs for veterinary use. The firm focuses on farm animal health and companion animal health. The company was founded by Bertrand Mérot in June 2011 and is headquartered in Liege, Belgium. | Biotechnology | Director/Board Member | |
ACTICOR BIOTECH SAS | Biotechnology | Director/Board Member | |
Ncardia SA
![]() Ncardia SA Miscellaneous Commercial ServicesCommercial Services Ncardia SA engages in drug discovery research and development. Its cardiac products encompass hiPSC-derived Pluricyte, Cardiomyocytes, Cor.4U cardiomyocytes and vCor.4U ventricular cardiomyocytes and FibroCor.4U cardiac fibroblasts. The company is headquartered in Gosselies, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
Newton Biocapital Partners SRL
![]() Newton Biocapital Partners SRL Investment ManagersFinance Newton Biocapital Partners SPRL is an Independent Venture Capital firm founded in 2017 by Alain Parthoens. Newton Biocapital Partners SPRL is headquartered in Woluwe-Saint-Pierre. | Investment Managers | Founder | |
AQ Partners SRL | Corporate Officer/Principal | ||
Epics Therapeutics SA
![]() Epics Therapeutics SA Miscellaneous Commercial ServicesCommercial Services EPICS Therapeutics SA engages in the development of therapeutic solutions for cancer. The company was founded by Jean Combalbert, Alain Parthoens and Francois Fuks on February 20, 2018 and is headquartered in Charleroi, Belgium. | Miscellaneous Commercial Services | Founder | |
Fuli Holdings Ltd.
![]() Fuli Holdings Ltd. Electronic ComponentsElectronic Technology Fuli Holdings Ltd. operates as an investment holding company. It offers manufacturing and sales of processed polarisers through its subsidiaries. Fuli Holdings was founded on October 8, 2020 and is headquartered in Huizhou, China. | Electronic Components | Director/Board Member | |
Kwong Ming Amusement Co. Ltd. | Director/Board Member | ||
Peterfame Co. Ltd. | Director/Board Member | ||
Haotian Development Group Co. Ltd. | Director/Board Member | ||
Ncardia Holding SA
![]() Ncardia Holding SA BiotechnologyHealth Technology Ncardia Holding SA provides biotech research and development, business management consulting, technical testing, and administrative services. The private company is based in Mont-Saint-Guibert, Belgium. The Belgian company was founded in 2014. Stefan Braam has been the CEO of the company since 2015. | Biotechnology | Director/Board Member | |
Cellaïon SA
![]() Cellaïon SA BiotechnologyHealth Technology Cellaïon SA is a biotech company located in Mont Saint Guibert, Belgium. Cellaïon aims to restore a favorable environment to reboost the regenerative process of the liver and ensure a second life to the native liver instead of losing it. The Belgian company has a strong IP base issued from their own research and academic research at UCLouvain, developed with the objective to generate new products. Cellaïon's treatment covers the wide spectrum of liver diseases, from the highly life-threatening acute-on-chronic liver-failure (ACLF) and acute alcoholic hepatitis, to intermediate severity acute decompensation of cirrhosis (AD) and progressive chronic liver diseases caused by non-alcoholic steatohepatitis (NASH). The company has built up a series of R&D and collaborative partnerships with both industrial and academic partners, allowing Cellaïon to broaden and accelerate its clinical development. The company was founded by Etienne Marc Sokal, who has been the CEO since incorporation. | Biotechnology | Director/Board Member Founder Chief Operating Officer | |
A Q Invest SRL | Corporate Officer/Principal |
Statistics
International
Belgium | 21 |
Hong Kong | 12 |
United Kingdom | 5 |
Luxembourg | 3 |
France | 3 |
Sectoral
Health Technology | 11 |
Commercial Services | 11 |
Consumer Services | 6 |
Finance | 5 |
Retail Trade | 2 |
Operational
Director/Board Member | 35 |
Corporate Officer/Principal | 12 |
Founder | 5 |
Undergraduate Degree | 3 |
Graduate Degree | 2 |
Most connected contacts
Insiders | |
---|---|
Alain Parthoens | 29 |
Chi Tak Fok | 16 |
Etienne Marc Sokal | 4 |
Eric Pauly | 2 |
Zimeng Dong | 1 |
Edward Haack | 1 |
Shintaro Hayashi | 1 |
Mustapha Najimi | 1 |
- Stock Market
- Insiders
- Houssam Zazgad
- Company connections